1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Paediatrics 1.2.3 Adolescence 1.2.4 Adults 1.2.5 Elderly 1.3 Market by Application 1.3.1 Global Seasonal Influenza Vaccines Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Seasonal Influenza Vaccines Therapeutics Market Perspective (2016-2027) 2.2 Seasonal Influenza Vaccines Therapeutics Growth Trends by Regions 2.2.1 Seasonal Influenza Vaccines Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Seasonal Influenza Vaccines Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Seasonal Influenza Vaccines Therapeutics Industry Dynamic 2.3.1 Seasonal Influenza Vaccines Therapeutics Market Trends 2.3.2 Seasonal Influenza Vaccines Therapeutics Market Drivers 2.3.3 Seasonal Influenza Vaccines Therapeutics Market Challenges 2.3.4 Seasonal Influenza Vaccines Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Seasonal Influenza Vaccines Therapeutics Players by Revenue 3.1.1 Global Top Seasonal Influenza Vaccines Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Seasonal Influenza Vaccines Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Seasonal Influenza Vaccines Therapeutics Revenue 3.4 Global Seasonal Influenza Vaccines Therapeutics Market Concentration Ratio 3.4.1 Global Seasonal Influenza Vaccines Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccines Therapeutics Revenue in 2020 3.5 Seasonal Influenza Vaccines Therapeutics Key Players Head office and Area Served 3.6 Key Players Seasonal Influenza Vaccines Therapeutics Product Solution and Service 3.7 Date of Enter into Seasonal Influenza Vaccines Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Seasonal Influenza Vaccines Therapeutics Breakdown Data by Type 4.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2022-2027) 5 Seasonal Influenza Vaccines Therapeutics Breakdown Data by Application 5.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027) 6.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type 6.2.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027) 6.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application 6.3.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027) 6.4 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country 6.4.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027) 7.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type 7.2.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027) 7.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application 7.3.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027) 7.4 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country 7.4.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type 8.2.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application 8.3.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region 8.4.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027) 9.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type 9.2.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application 9.3.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country 9.4.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type 10.2.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application 10.3.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country 10.4.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 GSK 11.1.1 GSK Company Details 11.1.2 GSK Business Overview 11.1.3 GSK Seasonal Influenza Vaccines Therapeutics Introduction 11.1.4 GSK Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) 11.1.5 GSK Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Introduction 11.2.4 Novartis Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 CSL 11.3.1 CSL Company Details 11.3.2 CSL Business Overview 11.3.3 CSL Seasonal Influenza Vaccines Therapeutics Introduction 11.3.4 CSL Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) 11.3.5 CSL Recent Development 11.4 MedImmune 11.4.1 MedImmune Company Details 11.4.2 MedImmune Business Overview 11.4.3 MedImmune Seasonal Influenza Vaccines Therapeutics Introduction 11.4.4 MedImmune Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) 11.4.5 MedImmune Recent Development 11.5 Sanofi-Pasteur 11.5.1 Sanofi-Pasteur Company Details 11.5.2 Sanofi-Pasteur Business Overview 11.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Introduction 11.5.4 Sanofi-Pasteur Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) 11.5.5 Sanofi-Pasteur Recent Development 11.6 Solvay 11.6.1 Solvay Company Details 11.6.2 Solvay Business Overview 11.6.3 Solvay Seasonal Influenza Vaccines Therapeutics Introduction 11.6.4 Solvay Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) 11.6.5 Solvay Recent Development 11.7 Hualan Biological Engineering 11.7.1 Hualan Biological Engineering Company Details 11.7.2 Hualan Biological Engineering Business Overview 11.7.3 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Introduction 11.7.4 Hualan Biological Engineering Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) 11.7.5 Hualan Biological Engineering Recent Development 11.8 Sinovac Biotech 11.8.1 Sinovac Biotech Company Details 11.8.2 Sinovac Biotech Business Overview 11.8.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Introduction 11.8.4 Sinovac Biotech Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) 11.8.5 Sinovac Biotech Recent Development 11.9 Changchun Institute of Biological Products Co., Ltd. 11.9.1 Changchun Institute of Biological Products Co., Ltd. Company Details 11.9.2 Changchun Institute of Biological Products Co., Ltd. Business Overview 11.9.3 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Introduction 11.9.4 Changchun Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) 11.9.5 Changchun Institute of Biological Products Co., Ltd. Recent Development 11.10 Shanghai Institute of Biological Products Co., Ltd. 11.10.1 Shanghai Institute of Biological Products Co., Ltd. Company Details 11.10.2 Shanghai Institute of Biological Products Co., Ltd. Business Overview 11.10.3 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Introduction 11.10.4 Shanghai Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) 11.10.5 Shanghai Institute of Biological Products Co., Ltd. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Paediatrics Table 3. Key Players of Adolescence Table 4. Key Players of Adults Table 5. Key Players of Elderly Table 6. Global Seasonal Influenza Vaccines Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Seasonal Influenza Vaccines Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Seasonal Influenza Vaccines Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Seasonal Influenza Vaccines Therapeutics Market Share by Regions (2016-2021) Table 10. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Seasonal Influenza Vaccines Therapeutics Market Share by Regions (2022-2027) Table 12. Seasonal Influenza Vaccines Therapeutics Market Trends Table 13. Seasonal Influenza Vaccines Therapeutics Market Drivers Table 14. Seasonal Influenza Vaccines Therapeutics Market Challenges Table 15. Seasonal Influenza Vaccines Therapeutics Market Restraints Table 16. Global Seasonal Influenza Vaccines Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Seasonal Influenza Vaccines Therapeutics Market Share by Players (2016-2021) Table 18. Global Top Seasonal Influenza Vaccines Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2020) Table 19. Ranking of Global Top Seasonal Influenza Vaccines Therapeutics Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Seasonal Influenza Vaccines Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Seasonal Influenza Vaccines Therapeutics Product Solution and Service Table 23. Date of Enter into Seasonal Influenza Vaccines Therapeutics Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 26. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2016-2021) Table 27. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Seasonal Influenza Vaccines Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2016-2021) Table 31. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 34. North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 36. North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 63. GSK Company Details Table 64. GSK Business Overview Table 65. GSK Seasonal Influenza Vaccines Therapeutics Product Table 66. GSK Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million) Table 67. GSK Recent Development Table 68. Novartis Company Details Table 69. Novartis Business Overview Table 70. Novartis Seasonal Influenza Vaccines Therapeutics Product Table 71. Novartis Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million) Table 72. Novartis Recent Development Table 73. CSL Company Details Table 74. CSL Business Overview Table 75. CSL Seasonal Influenza Vaccines Therapeutics Product Table 76. CSL Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million) Table 77. CSL Recent Development Table 78. MedImmune Company Details Table 79. MedImmune Business Overview Table 80. MedImmune Seasonal Influenza Vaccines Therapeutics Product Table 81. MedImmune Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million) Table 82. MedImmune Recent Development Table 83. Sanofi-Pasteur Company Details Table 84. Sanofi-Pasteur Business Overview Table 85. Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product Table 86. Sanofi-Pasteur Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million) Table 87. Sanofi-Pasteur Recent Development Table 88. Solvay Company Details Table 89. Solvay Business Overview Table 90. Solvay Seasonal Influenza Vaccines Therapeutics Product Table 91. Solvay Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million) Table 92. Solvay Recent Development Table 93. Hualan Biological Engineering Company Details Table 94. Hualan Biological Engineering Business Overview Table 95. Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Product Table 96. Hualan Biological Engineering Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million) Table 97. Hualan Biological Engineering Recent Development Table 98. Sinovac Biotech Company Details Table 99. Sinovac Biotech Business Overview Table 100. Sinovac Biotech Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million) Table 101. Sinovac Biotech Recent Development Table 102. Changchun Institute of Biological Products Co., Ltd. Company Details Table 103. Changchun Institute of Biological Products Co., Ltd. Business Overview Table 104. Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product Table 105. Changchun Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million) Table 106. Changchun Institute of Biological Products Co., Ltd. Recent Development Table 107. Shanghai Institute of Biological Products Co., Ltd. Company Details Table 108. Shanghai Institute of Biological Products Co., Ltd. Business Overview Table 109. Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product Table 110. Shanghai Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million) Table 111. Shanghai Institute of Biological Products Co., Ltd. Recent Development Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Global Seasonal Influenza Vaccines Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Paediatrics Features Figure 3. Adolescence Features Figure 4. Adults Features Figure 5. Elderly Features Figure 6. Global Seasonal Influenza Vaccines Therapeutics Market Share by Application: 2020 VS 2027 Figure 7. Hospitals Case Studies Figure 8. Clinics Case Studies Figure 9. Others Case Studies Figure 10. Seasonal Influenza Vaccines Therapeutics Report Years Considered Figure 11. Global Seasonal Influenza Vaccines Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Seasonal Influenza Vaccines Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Seasonal Influenza Vaccines Therapeutics Market Share by Regions: 2020 VS 2027 Figure 14. Global Seasonal Influenza Vaccines Therapeutics Market Share by Regions (2022-2027) Figure 15. Global Seasonal Influenza Vaccines Therapeutics Market Share by Players in 2020 Figure 16. Global Top Seasonal Influenza Vaccines Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Seasonal Influenza Vaccines Therapeutics Revenue in 2020 Figure 18. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2016-2021) Figure 19. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2022-2027) Figure 20. North America Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027) Figure 22. North America Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027) Figure 23. North America Seasonal Influenza Vaccines Therapeutics Market Share by Country (2016-2027) Figure 24. United States Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027) Figure 28. Europe Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027) Figure 29. Europe Seasonal Influenza Vaccines Therapeutics Market Share by Country (2016-2027) Figure 30. Germany Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027) Figure 38. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027) Figure 39. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Share by Region (2016-2027) Figure 40. China Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027) Figure 48. Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027) Figure 49. Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Country (2016-2027) Figure 50. Mexico Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027) Figure 54. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027) Figure 55. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Share by Country (2016-2027) Figure 56. Turkey Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. GSK Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) Figure 60. Novartis Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) Figure 61. CSL Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) Figure 62. MedImmune Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) Figure 63. Sanofi-Pasteur Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) Figure 64. Solvay Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) Figure 65. Hualan Biological Engineering Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) Figure 66. Sinovac Biotech Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) Figure 67. Changchun Institute of Biological Products Co., Ltd. Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) Figure 68. Shanghai Institute of Biological Products Co., Ltd. Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

GSK Novartis CSL MedImmune Sanofi-Pasteur Solvay Hualan Biological Engineering Sinovac Biotech Changchun Institute of Biological Products Co., Ltd. Shanghai Institute of Biological Products Co., Ltd.